Biodonostia Institute, Hospital Donostia, P Doctor Begiristain, Donostia, Spain.
Transl Psychiatry. 2013 Jan 22;3(1):e219. doi: 10.1038/tp.2012.147.
1-42 β-Amyloid (Aβ(1-42)) peptide is a key molecule involved in the development of Alzheimer's disease. Some of its effects are manifested at the neuronal morphological level. These morphological changes involve loss of neurites due to cytoskeleton alterations. However, the mechanism of Aβ(1-42) peptide activation of the neurodegenerative program is still poorly understood. Here, Aβ(1-42) peptide-induced transduction of cellular death signals through the phosphatidylinositol 3-kinase (PI3K)/phosphoinositol-dependent kinase (PDK)/novel protein kinase C (nPKC)/Rac 1 axis is described. Furthermore, pharmacological inhibition of PDK1 and nPKC activities blocks Rac 1 activation and neuronal cell death. Our results provide insights into an unsuspected connection between PDK1, nPKCs and Rac 1 in the same signal-transduction pathway and points out nPKCs and Rac 1 as potential therapeutic targets to block the toxic effects of Aβ(1-42) peptide in neurons.
1-42β-淀粉样蛋白(Aβ(1-42))肽是参与阿尔茨海默病发展的关键分子。其部分作用表现在神经元形态学水平。这些形态变化涉及到由于细胞骨架改变导致的神经突起丧失。然而,Aβ(1-42)肽激活神经退行性病变程序的机制仍知之甚少。在这里,描述了 Aβ(1-42)肽通过磷酸肌醇 3-激酶(PI3K)/磷酸肌醇依赖性激酶(PDK)/新型蛋白激酶 C(nPKC)/Rac1 轴诱导细胞死亡信号转导。此外,PDK1 和 nPKC 活性的药理学抑制阻断 Rac1 的激活和神经元细胞死亡。我们的结果提供了对 PDK1、nPKCs 和 Rac1 在同一信号转导途径中的意外联系的深入了解,并指出 nPKCs 和 Rac1 是阻止 Aβ(1-42)肽在神经元中产生毒性作用的潜在治疗靶点。